Search results for "Transgenics"

showing 5 items of 5 documents

Aequorin-expressing yeast emits light under electric control

2011

In this study, we show the use of direct external electrical stimulation of a jellyfish luminescent calcium-activated protein, aequorin, expressed in a transgenic yeast strain. Yeast cultures were electrically stimulated through two electrodes coupled to a standard power generator. Even low (1.5. V) electric pulses triggered a rapid light peak and serial light pulses were obtained after electric pulses were applied periodically, suggesting that the system is re-enacted after a short refraction time. These results open up a new scenario, in the very interphase between synthetic biology and cybernetics, in which complex cellular behavior might be subjected to electrical control.

Activated proteinsLightScyphozoaAequorinApplied Microbiology and BiotechnologyElectricityHydroxidesCellular behaviorsPriority journalYeast electro-stimulationbiologyPhosphorescencePower generatorsGeneral MedicineElectrostimulationMAQUINAS Y MOTORES TERMICOSElectrodeElectric pulseInterphaseBioluminescenceYeast cultureGenetic EngineeringMATEMATICA APLICADABiotechnologyPotassium CompoundsLight pulse generatorsSaccharomyces cerevisiaeBioengineeringNanotechnologyLight pulseSaccharomyces cerevisiaeElectrical stimulationsYeast strainArticleAequorinBioluminescenceBiologySynthetic biologyBioelectronicsBioelectronicsbiology.organism_classificationElectric controlYeastElectric StimulationYeastFISICA APLICADABiophysicsbiology.proteinProtein expressionJellyfishElectrical controlLuminescenceCell functionTransgenics
researchProduct

AAV vector-mediated overexpression of CB1 cannabinoid receptor in pyramidal neurons of the hippocampus protects against seizure-induced excitoxicity.

2010

The CB1 cannabinoid receptor is the most abundant G-protein coupled receptor in the brain and a key regulator of neuronal excitability. There is strong evidence that CB1 receptor on glutamatergic hippocampal neurons is beneficial to alleviate epileptiform seizures in mouse and man. Therefore, we hypothesized that experimentally increased CB1 gene dosage in principal neurons would have therapeutic effects in kainic acid (KA)-induced hippocampal pathogenesis. Here, we show that virus-mediated conditional overexpression of CB1 receptor in pyramidal and mossy cells of the hippocampus is neuroprotective and moderates convulsions in the acute KA seizure model in mice. We introduce a recombinant a…

Central Nervous SystemCannabinoid receptormedicine.medical_treatmentHippocampuslcsh:MedicineHippocampal formationHippocampuschemistry.chemical_compoundMiceReceptor Cannabinoid CB1Neurobiology of Disease and RegenerationTransgeneslcsh:ScienceNeuronsRecombination GeneticMultidisciplinaryBehavior AnimalNeuromodulationmusculoskeletal neural and ocular physiologyfood and beveragesNeurochemistryGenomicsGene TherapyDependovirusEndocannabinoid systemCell biologyFunctional GenomicsNeurologyHomeostatic MechanismsMedicinelipids (amino acids peptides and proteins)Viral VectorsNeurochemicalsGenetic EngineeringResearch ArticleBiotechnologyKainic acidGenetic VectorsGreen Fluorescent ProteinsNeurophysiologyBiologyMicrobiologyVector BiologyGlutamatergicGenomic MedicineSeizuresmedicineGeneticsAnimalsBiologyEpilepsyIntegrasesDentate gyruslcsh:RMolecular biologyMice Inbred C57BLchemistryGene Expression Regulationnervous systemGenetics of DiseaseSynapseslcsh:QCannabinoidGene FunctionMolecular NeuroscienceAnimal GeneticsTransgenicsNeuroscienceEndocannabinoidsPLoS ONE
researchProduct

Revised annual post-market environmental monitoring (PMEM) report on the cultivation of genetically modified maize MON 810 in 2013 from Monsanto Euro…

2015

Question number: EFSA-Q-2015-00432On request from: European Commission; Following a request from the European Commission, the Panel on Genetically Modified Organisms of the European Food Safety Authority (EFSA GMO Panel) assessed the results of the general surveillance activities contained in the revised annual post-market environmental monitoring (PMEM) report for the 2013 growing season of maize MON 810 provided by Monsanto Europe S.A. The supplied data do not indicate any unanticipated adverse effects on human and animal health or the environment arising from the cultivation of maize MON 810 cultivation in 2013. Similar methodological shortcomings to those observed in previous annual PME…

MON 810literature review[SDV]Life Sciences [q-bio]Veterinary (miscellaneous)reviewTP1-1185Plant Sciencegenetically engineered organismmaizeenvironmental impactZea maysMicrobiologyAgricultural scienceadverse effectEnvironmental monitoringTX341-641Cry1Abliterature searchestransgenic plant2. Zero hungergenetic engineeringGenetically modified maizeanimal healthNutrition. Foods and food supplyeffectChemical technologyquestionnairescreeningtransgenicsliteraturegeneral surveillancerisk assessmenthealthmethodology10079 Institute of Veterinary Pharmacology and Toxicologyfarmer questionnairestechniqueadverse effects; animal health; cultivation; effects; environmental impact; food safety; genetic engineering; genetically engineered organisms; guidelines; health; impact; literature; literature reviews; maize; methodology; monitoring; questionnaires; reviews; risk assessment; screening; techniques; transgenic plants; transgenicsfood safetymonitoringSettore AGR/11 - Entomologia Generale E ApplicataGeographycultivationimpact570 Life sciences; biologyAnimal Science and ZoologyParasitologyguidelineFood Science
researchProduct

Glial Promoter Selectivity following AAV-Delivery to the Immature Brain

2013

Recombinant adeno-associated virus (AAV) vectors are versatile tools for gene transfer to the central nervous system (CNS) and proof-of-concept studies in adult rodents have shown that the use of cell type-specific promoters is sufficient to target AAV-mediated transgene expression to glia. However, neurological disorders caused by glial pathology usually have an early onset. Therefore, modelling and treatment of these conditions require expanding the concept of targeted glial transgene expression by promoter selectivity for gene delivery to the immature CNS. Here, we have investigated the AAV-mediated green fluorescent protein (GFP) expression driven by the myelin basic protein (MBP) or gl…

MouseCanavan DiseaseGene ExpressionDevelopmental and Pediatric NeurologyPediatricsGreen fluorescent protein0302 clinical medicineGene expressionNeurobiology of Disease and RegenerationTransgenesPromoter Regions GeneticCells Cultured0303 health sciencesMultidisciplinaryGlial fibrillary acidic proteinQStatisticsRAge FactorsBrainGenomicsGene TherapyAnimal ModelsDependovirusOligodendrogliamedicine.anatomical_structureNeurologyOrgan SpecificityMedicineGenetic EngineeringResearch ArticleBiotechnologyScienceTransgeneCentral nervous systemGenetic VectorsGreen Fluorescent ProteinsGene deliveryBiologyBiostatistics03 medical and health sciencesModel OrganismsGenomic MedicineDevelopmental NeuroscienceNeuroglial DevelopmentGlial Fibrillary Acidic ProteinmedicineGeneticsAnimalsBiology030304 developmental biologyClinical GeneticsMyelin Basic ProteinGenetic TherapyMolecular biologyOligodendrocyteMyelin basic proteinMice Inbred C57BLAnimals NewbornAstrocytesbiology.protein030217 neurology & neurosurgeryMathematicsTransgenicsNeurosciencePLoS ONE
researchProduct

Effects of the silencing of sorbitol dehydrogenase on sugar partitioning in vegetative sinks in apple

2011

carbohydrate – leaves – Malus – SDH – sorbitol – transgenics
researchProduct